Search research articles
Contact Us
Filters
Showing results (231-240 of 332) with videos related to
Page
of 34
Sort By:
International Journal of Molecular Sciences
|
January 27, 2019
Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6'-Dithiothalidomide on Traumatic Brain Injury
Buyandelger Batsaikhan, Jing-Ya Wang, Michael T Scerba, et al.
Iscience
|
February 15, 2020
Post-treatment with Posiphen Reduces Endoplasmic Reticulum Stress and Neurodegeneration in Stroke Brain
Seong-Jin Yu, Kuo-Jen Wu, Eunkyung Bae, et al.
Journal of Alzheimer'S Disease : JAD
|
September 22, 2006
Neurine, an acetylcholine autolysis product, elevates secreted amyloid-beta protein precursor and amyloid-beta peptide levels, and lowers neuronal cell viability in culture: a role in Alzheimer's disease?
David Tweedie, Arnold Brossi, DeMoa Chen, et al.
Behavioural Brain Research
|
August 9, 2011
Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice
Yoko Furukawa-Hibi, Tursun Alkam, Atsumi Nitta, et al.
Acta Neurobiologiae Experimentalis
|
June 12, 2004
Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases
Nigel H Greig, Tony Giordano, Xiaoxiang Zhu, et al.
Journal of Medicinal Chemistry
|
March 31, 2006
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine
Weiming Luo, Qian-Sheng Yu, Santosh S Kulkarni, et al.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
|
January 31, 2013
Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and cholinergic action
Qian-Sheng Yu, Marcella Reale, Mohammad A Kamal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 10, 2020
Traumatic brain injury increases plasma astrocyte-derived exosome levels of neurotoxic complement proteins
Edward J Goetzl, Kristine Yaffe, Carrie B Peltz, et al.
Journal of Neuroinflammation
|
January 5, 2022
Diphtheria toxin induced but not CSF1R inhibitor mediated microglia ablation model leads to the loss of CSF/ventricular spaces in vivo that is independent of cytokine upregulation
Alicia Bedolla, Aleksandr Taranov, Fucheng Luo, et al.
Endocrine
|
August 4, 2005
In vivo biological activity of exendin (1-30)
Máire E Doyle, Patrick McConville, Michael J Theodorakis, et al.
Page
of 34
Search research articles
Search
Showing results (231-240 of 332) with videos related to
Sort By:
Page
of 34
International Journal of Molecular Sciences
|
January 27, 2019
Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6'-Dithiothalidomide on Traumatic Brain Injury
Buyandelger Batsaikhan, Jing-Ya Wang, Michael T Scerba, et al.
Iscience
|
February 15, 2020
Post-treatment with Posiphen Reduces Endoplasmic Reticulum Stress and Neurodegeneration in Stroke Brain
Seong-Jin Yu, Kuo-Jen Wu, Eunkyung Bae, et al.
Journal of Alzheimer'S Disease : JAD
|
September 22, 2006
Neurine, an acetylcholine autolysis product, elevates secreted amyloid-beta protein precursor and amyloid-beta peptide levels, and lowers neuronal cell viability in culture: a role in Alzheimer's disease?
David Tweedie, Arnold Brossi, DeMoa Chen, et al.
Behavioural Brain Research
|
August 9, 2011
Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice
Yoko Furukawa-Hibi, Tursun Alkam, Atsumi Nitta, et al.
Acta Neurobiologiae Experimentalis
|
June 12, 2004
Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases
Nigel H Greig, Tony Giordano, Xiaoxiang Zhu, et al.
Journal of Medicinal Chemistry
|
March 31, 2006
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine
Weiming Luo, Qian-Sheng Yu, Santosh S Kulkarni, et al.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
|
January 31, 2013
Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and cholinergic action
Qian-Sheng Yu, Marcella Reale, Mohammad A Kamal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 10, 2020
Traumatic brain injury increases plasma astrocyte-derived exosome levels of neurotoxic complement proteins
Edward J Goetzl, Kristine Yaffe, Carrie B Peltz, et al.
Journal of Neuroinflammation
|
January 5, 2022
Diphtheria toxin induced but not CSF1R inhibitor mediated microglia ablation model leads to the loss of CSF/ventricular spaces in vivo that is independent of cytokine upregulation
Alicia Bedolla, Aleksandr Taranov, Fucheng Luo, et al.
Endocrine
|
August 4, 2005
In vivo biological activity of exendin (1-30)
Máire E Doyle, Patrick McConville, Michael J Theodorakis, et al.
Page
of 34